These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9329607)

  • 21. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
    Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
    Battaglia F; Scambia G; Panici PB; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
    Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer.
    Takeshima N; Hirai Y; Katase K; Yano K; Yamauchi K; Hasumi K
    Gynecol Oncol; 1998 Mar; 68(3):263-6. PubMed ID: 9570978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations.
    Massuger LF; Koper NP; Thomas CM; Dom KE; Schijf CP
    Gynecol Oncol; 1997 Mar; 64(3):473-6. PubMed ID: 9062153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A; Nakano T; Morita S; Oka K
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of serum levels of SCC antigen in cancers of the oral cavity].
    Yoshida H; Kinehara M; Sato K
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3595-601. PubMed ID: 2817910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
    Molina R; Filella X; Augé JM; Bosch E; Torne A; Pahisa J; Lejarcegui JA; Rovirosa A; Mellado B; Ordi J; Biete A
    Anticancer Res; 2005; 25(3A):1765-71. PubMed ID: 16033097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
    Micke O; Prott FJ; Schäfer U; Tangerding S; Pötter R; Willich N
    Anticancer Res; 2000; 20(6D):5113-5. PubMed ID: 11326679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma].
    Ychou M; Khemissa-Akouz F; Kramar A; Senesse P; Grenier J
    Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma.
    Nagler RM; Barak M; Peled M; Ben-Aryeh H; Filatov M; Laufer D
    Cancer; 1999 Mar; 85(5):1018-25. PubMed ID: 10091783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM
    Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of marker antigens TPS, SCC and CEA in diagnosis, evaluation of histologic type and clinical disease progression in patients with cervical carcinoma].
    Zakrzewska I
    Pol Merkur Lekarski; 2001 Jan; 10(55):21-3. PubMed ID: 11320545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
    Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
    Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.